Tuberous sclerosis is a rare, multi-system genetic disease that causes benign tumors to grow in the brain and other vital organs like kidneys, heart, eyes, lungs, and skin.
Prevalance of Tuberous sclerosis is reported to be less than 1 in 10,000 of population. Tuberous sclerosis is listed as a "rare disease" by the Office of Rare Diseases (ORD)
Specific medications may be prescribed for behaviour problems. Intervention programs including special schooling and occupational therapy may benefit individuals with special needs and developmental issues.
Researches are focusing on facilitating the development of a major early invention study. This is likely to be based around the use of an mTOR inhibitor to in early childhood.